ArticleFrontiers in immunology2025

Tumor-restricted activation of Vγ9Vδ2 T cells via bispecific Evobodies: a novel strategy for safe and potent immunotherapy in ovarian cancer.

Hans-Heinrich Oberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.